인쇄하기
취소
|
Last year, KOSPI listed pharmaceutical companies had a decrease in the average R&D expenses year-on-year, and KOSDAQ listed pharmaceutical companies had an increase. When it comes to the R&D expense/sales rate, KOSPI pharmaceutical companies had a higher figure than what KOSDAQ pharmaceutical companies had.
Yakup Shinmoon(www.yakup.com) analyzed R&D expenses that 39 KOSPI and 32 KOSDAQ listed ...